Veldlaser is industriepartner in RegMed.
Regenerative medicine aims to restore degenerated, diseased or damaged tissues and organs, thereby increasing vital functioning and reducing the cost of healthcare. RegMed XB brings together multiple health foundations, top scientists, entrepreneurs and governments to cooperatively tackle ambitious challenges in regenerative medicine. In RegMed XB, research and clinical translation are integrated to quickly and optimally bring research results into patient solutions and new businesses.